Inmune Bio, Inc.

INMB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
344
SEC Filings

Business Summary

Our Strategy Company Overview INmune Bio is a clinical-stage biotechnology company dedicated to developing and commercializing a pipeline of product candidates designed to reprogram the innate immune system. Our mission is to address a broad range of diseases where chronic inflammation and immune dysfunction are primary drivers of pathology. Lead Program : CORDStrom for RDEB Our primary focus is the treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) using CORDStrom, our proprietary, ...

Next Earnings

Q2 FY2026 — expected 2026-09-21

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionINMBdiscussed_in_filing Cybersecurity
topic_mentionINMBdiscussed_in_filing Trusted Computing
topic_mentionINMBdiscussed_in_filing Blockchain & Crypto
topic_mentionINMBdiscussed_in_filing Supply Chain
topic_mentionINMBdiscussed_in_filing Regulation
topic_mentionINMBdiscussed_in_filing Healthcare & Bio
topic_mentionINMBdiscussed_in_filing Platform & Ecosystem
topic_mentionINMBdiscussed_in_filing Sovereign & Government
topic_mentionINMBdiscussed_in_filing Cybersecurity
topic_mentionINMBdiscussed_in_filing Trusted Computing
topic_mentionINMBdiscussed_in_filing Blockchain & Crypto
topic_mentionINMBdiscussed_in_filing Supply Chain
topic_mentionINMBdiscussed_in_filing Regulation
topic_mentionINMBdiscussed_in_filing Healthcare & Bio
topic_mentionINMBdiscussed_in_filing Platform & Ecosystem
topic_mentionINMBdiscussed_in_filing Sovereign & Government
topic_mentionINMBdiscussed_in_filing Cybersecurity
topic_mentionINMBdiscussed_in_filing Trusted Computing
topic_mentionINMBdiscussed_in_filing Blockchain & Crypto
topic_mentionINMBdiscussed_in_filing Supply Chain

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001213900-26-036370EDGAR60K words
2025-03-272024-12-310001013762-25-003354EDGAR—
2024-03-282023-12-310001213900-24-027206EDGAR—
2023-03-022022-12-310001213900-23-016875EDGAR—
2022-03-032021-12-310001213900-22-010573EDGAR—
2021-03-042020-12-310001213900-21-013456EDGAR—
2020-03-112019-12-310001213900-20-005916EDGAR—
2019-03-292018-12-310001640334-19-000466EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001213900-25-104141EDGAR20K words
2025-08-072025-06-300001213900-25-073077EDGAR—
2025-05-082025-03-310001213900-25-041072EDGAR—
2024-10-312024-09-300001213900-24-092861EDGAR—
2024-08-012024-06-300001213900-24-064076EDGAR—
2024-05-092024-03-310001213900-24-041286EDGAR—
2023-11-012023-09-300001213900-23-082167EDGAR—
2023-08-072023-06-300001213900-23-064057EDGAR—
2023-05-032023-03-310001213900-23-035972EDGAR—
2022-11-022022-09-300001213900-22-068637EDGAR—
2022-08-032022-06-300001213900-22-044453EDGAR—
2022-05-052022-03-310001213900-22-024226EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001213900-26-021120EDGAR5K words
2026-02-230001213900-26-019321EDGAR—
2026-02-190001213900-26-018396EDGAR—
2026-02-130001213900-26-016385EDGAR—
2026-01-270001213900-26-008204EDGAR—
2025-12-230001213900-25-125282EDGAR—
2025-12-190001213900-25-123880EDGAR—
2025-12-100001213900-25-120067EDGAR—
2025-12-080001213900-25-119217EDGAR—
2025-12-050001213900-25-118699EDGAR—

344 total filings indexed. 314 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001711754
TickerINMB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 386f67de289908f036652880f9cb48096e0f9f5eddc261e8876c498e3a52d0bf
parent: fe54d9ccc0cb81eba93ad8060c6ab4486544474a0c90464c9a11547e65b848ab
content hash: 62b4db41cb37a73ddf6b20ad26bc7020e5d3ee70cd0cf9c778dfce3a8cec2719
signed: 2026-04-13T04:45:42.228Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf